Sukanto Sinha

8.8k total citations · 2 hit papers
49 papers, 5.8k citations indexed

About

Sukanto Sinha is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, Sukanto Sinha has authored 49 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 22 papers in Physiology and 7 papers in Pharmacology. Recurrent topics in Sukanto Sinha's work include Alzheimer's disease research and treatments (21 papers), Cholinesterase and Neurodegenerative Diseases (7 papers) and Computational Drug Discovery Methods (6 papers). Sukanto Sinha is often cited by papers focused on Alzheimer's disease research and treatments (21 papers), Cholinesterase and Neurodegenerative Diseases (7 papers) and Computational Drug Discovery Methods (6 papers). Sukanto Sinha collaborates with scholars based in United States, United Kingdom and Australia. Sukanto Sinha's co-authors include Ivan Lieberburg, Peter Seubert, Harry F. Dovey, Dale Schenk, D. H. S. Davis, Robert L. Wolfert, Michael Lee, Fred Esch, Robert McCormack and Dennis J. Selkoe and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Sukanto Sinha

48 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids

1992 1.5k citations Peter Seubert, Harry F. Dovey et al. Nature profile →
Phosphorylation of Ser-129 Is the Dominant Pathological Modification of α-Synuclein in Familial and Sporadic Lewy Body Disease

2006 1.1k citations John P. Anderson, Donald E. Walker et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by Sukanto Sinha

Since Specialization

Citations

This map shows the geographic impact of Sukanto Sinha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sukanto Sinha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sukanto Sinha more than expected).

Fields of papers citing papers by Sukanto Sinha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sukanto Sinha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sukanto Sinha. The network helps show where Sukanto Sinha may publish in the future.

Co-authorship network of co-authors of Sukanto Sinha

This figure shows the co-authorship network connecting the top 25 collaborators of Sukanto Sinha. A scholar is included among the top collaborators of Sukanto Sinha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sukanto Sinha. Sukanto Sinha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nonclinical safety and pharmacology of RZ402, a plasma kallikrein inhibitor, for the treatment of diabetic macular edema as a daily oral therapy 2020 ·Investigative Ophthalmology & Visual Science ·(unknown), (unknown), Tamie J. Chilcote, Sukanto Sinha	3
2	Monitoring peri-ictal changes in heart rate variability, oxygen saturation and blood pressure in epilepsy monitoring unit 2016 ·Epilepsy Research ·(unknown), Ganne Chaitanya, P. Satishchandra, (unknown), K. Thennarasu, Sukanto Sinha	32
3	TIME-H in clinical practice - a pilot study 2013 ·eCite Digital Repository (University of Tasmania) ·(unknown), (unknown), Sukanto Sinha	1
4	Plasma Kallikrein Mediates Angiotensin II Type 1 Receptor–Stimulated Retinal Vascular Permeability 2009 ·Hypertension ·Joanna A. Phipps, Allen C. Clermont, Sukanto Sinha, Tamie J. Chilcote, Sven–Erik Bursell, Edward P. Feener	54
5	BACE1 gene deletion: Impact on behavioral function in a model of Alzheimer's disease 2007 ·Neurobiology of Aging ·Dione Kobayashi, (unknown), Tracy Cole, Manuel Buttini, Lisa McConlogue, Sukanto Sinha, Stephen B. Freedman, Richard Morris, Karen Chen	87
6	Partial Reduction of BACE1 Has Dramatic Effects on Alzheimer Plaque and Synaptic Pathology in APP Transgenic Mice 2007 ·Journal of Biological Chemistry ·Lisa McConlogue, Manuel Buttini, John P. Anderson, Elizabeth Brigham, Karen Chen, Stephen B. Freedman, Dora Games, Kelly Johnson‐Wood, Michael Lee, (unknown), Weiqun Liu, Ruth Motter, Sukanto Sinha	231
7	Phosphorylation of Ser-129 Is the Dominant Pathological Modification of α-Synuclein in Familial and Sporadic Lewy Body Disease breakdown → 2006 ·Journal of Biological Chemistry ·John P. Anderson, Donald E. Walker, Jason Goldstein, Rian de Laat, (unknown), Russell Caccavello, Robin Barbour, Jiping Huang, (unknown), Michael Lee, Linnea Diep, Pamela S. Keim, Xiaofeng Shen, Tim Chataway, Michael G. Schlossmacher, Peter Seubert, Dale Schenk, Sukanto Sinha, Wei Gai, Tamie J. Chilcote	1088
8	The evolution of a hospital based leg ulcer clinic 2003 ·eCite Digital Repository (University of Tasmania) ·Alex W. Hewitt, (unknown), (unknown), Sukanto Sinha	1
9	Antagonistic Effects of β-Site Amyloid Precursor Protein-cleaving Enzymes 1 and 2 on β-Amyloid Peptide Production in Cells 2003 ·Journal of Biological Chemistry ·Guriqbal S. Basi, Normand L. Frigon, Robin Barbour, (unknown), Grace Gordon, Lisa McConlogue, Sukanto Sinha, (unknown)	86
10	The role of beta-amyloid in Alzheimer's disease 2002 ·Medical Clinics of North America ·Sukanto Sinha	8
11	Retention of the Alzheimer's Amyloid Precursor Fragment C99 in the Endoplasmic Reticulum Prevents Formation of Amyloid β-Peptide 2001 ·Journal of Biological Chemistry ·William A. Maltese, Susan E. Wilson, Yizheng Tan, (unknown), Sukanto Sinha, Robin Barbour, Lisa McConlogue	46
12	Recent Advances in the Understanding of the Processing of APP to Beta Amyloid Peptide 2000 ·Annals of the New York Academy of Sciences ·Sukanto Sinha, J. P. Anderson, Varghese John, Lisa McConlogue, G.S. Basi, Eugene D. Thorsett, Dale Schenk	14
13	Activation of Multiple Interleukin-1β Converting Enzyme Homologues in Cytosol and Nuclei of HL-60 Cells during Etoposide-induced Apoptosis 1997 ·Journal of Biological Chemistry ·L. Miguel Martins, Timothy Kottke, Peter W. Mesner, Guriqbal S. Basi, Sukanto Sinha, Normand L. Frigon, (unknown), Jay S. Tung, (unknown), Atsushi Takahashi, Phyllis A. Svingen, Benjamin J. Madden, Daniel McCormick, William C. Earnshaw, Scott H. Kaufmann	198
14	β-Secretase Processing of the β-Amyloid Precursor Protein in Transgenic Mice Is Efficient in Neurons but Inefficient in Astrocytes 1996 ·Journal of Biological Chemistry ·Jun Zhao, (unknown), Lennart Mucke, (unknown), (unknown), M. D. Carman, Sukanto Sinha, Tilman Oltersdorf, Ivan Lieberburg, Lisa McConlogue	80
15	Cell-type and Amyloid Precursor Protein-type Specific Inhibition of Aβ Release by Bafilomycin A1, a Selective Inhibitor of Vacuolar ATPases 1995 ·Journal of Biological Chemistry ·Jeroen Knops, (unknown), Michael Lee, Lisa McConlogue, Peter Seubert, Sukanto Sinha	94
16	Regulated cleavage of alzheimer β-amyloid precursor protein in the absence of the cytoplasmic tail 1993 ·Neuroscience ·Odete A. B. da Cruz e Silva, Kerstin Iverfeldt, Tilman Oltersdorf, Sukanto Sinha, Ivan Lieberburg, T V Ramabhadran, Toshiharu Suzuki, Sangram S. Sisodia, Sam Gandy, Paul Greengard	60
17	Cells with a familial Alzheimerʼs disease mutation produce authentic β-peptide 1993 ·Neuroreport ·Harry F. Dovey, (unknown), Ivan Lieberburg, Sukanto Sinha, (unknown)	57
18	The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II 1989 ·Nature ·Tilman Oltersdorf, Lawrence C. Fritz, Dale B. Schenk, Ivan Lieberburg, Kelly Johnson‐Wood, Eric C. Beattie, Pamela J. Ward, Russell Blacher, Harry F. Dovey, Sukanto Sinha	391
19	Characterization of Sheep Alpha-1-Proteinase Inhibitor: Important Differences from the Human Protein 1988 ·American Review of Respiratory Disease ·(unknown), Sukanto Sinha, Aaron Janoff	14
20	Purification and Comparative Characterization of an Enolase from Spinach 1984 ·PLANT PHYSIOLOGY ·Sukanto Sinha, John M. Brewer	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact